http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101927614-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-1092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L79-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G73-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L79-08
filingDate 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101927614-B1
titleOfInvention Preparing method of contrast agent with stable oxygen-nanobubble or ultrasound imaging
abstract The present invention relates to a method for preparing a stable biocompatible oxygen-nano bubble contrast agent for ultrasound imaging, and more particularly, to a method for preparing a biocompatible oxygen- Poly (2-hydroxyethyl aspartamide) (hereinafter referred to as &quot; PHEA &quot;); Synthesizing an amphiphilic polyamino acid derivative represented by the following formula (1) by grafting the PHEA with a protoporphyrin compound contained in the center of iron; Mixing the synthesized amphiphilic polyamino acid derivative with a lipid to form a lipid thin film; And a step of injecting a solvent containing oxygen gas into the lipid thin film to prepare an oxygen-nano bubble in which oxygen gas is trapped, thereby producing an oxygen-nano bubble contrast agent composition for an ultrasonic wave. [Chemical Formula 1] In Formula 1, R 1 to R 10 may be the same or different, Hydrogen or an iron represented by the following formula (1-1) [Formula 1-1] N is an integer from 3 to 600; The method for preparing a stable biocompatible oxygen-nanobubble contrast agent for ultrasound imaging according to the present invention can synthesize an amphiphilic polyamino acid derivative by grafting a hydrophilic molecule-containing porphyrin compound to a hydrophilic polymer backbone, The amphipathic polyamino acid derivative can self-assemble with the lipid bilayer to stably capture the oxygen gas at the central portion, thereby making it possible to produce a biocompatible oxygen-nanobubble contrast agent.
priorityDate 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000504317-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013012443-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415794038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452170571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15061530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6021688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411319268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426096291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433298372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 54.